1. Home
  2. GOTU vs KROS Comparison

GOTU vs KROS Comparison

Compare GOTU & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GOTU

Gaotu Techedu Inc.

HOLD

Current Price

$2.38

Market Cap

580.9M

Sector

Real Estate

ML Signal

HOLD

Logo Keros Therapeutics Inc.

KROS

Keros Therapeutics Inc.

HOLD

Current Price

$21.36

Market Cap

655.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOTU
KROS
Founded
2014
2015
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
580.9M
655.9M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
GOTU
KROS
Price
$2.38
$21.36
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$22.20
AVG Volume (30 Days)
544.0K
1.0M
Earning Date
11-26-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.57
Revenue
$821,732,499.00
$246,718,000.00
Revenue This Year
$35.85
$6,876.34
Revenue Next Year
$19.75
N/A
P/E Ratio
N/A
$12.87
Revenue Growth
49.01
37798.31
52 Week Low
$1.87
$9.12
52 Week High
$4.56
$22.55

Technical Indicators

Market Signals
Indicator
GOTU
KROS
Relative Strength Index (RSI) 41.46 64.94
Support Level $2.31 $19.76
Resistance Level $2.43 $21.75
Average True Range (ATR) 0.07 1.10
MACD 0.01 -0.10
Stochastic Oscillator 32.00 78.47

Price Performance

Historical Comparison
GOTU
KROS

About GOTU Gaotu Techedu Inc.

Gaotu Techedu Inc is a technology-driven education company that provides online live courses in a large-class setting backed by its proprietary technology infrastructure. The company offers courses in large-class format, which amplifies the benefits of online education and allows it to rapidly expand its student base. It operates solely in the PRC and all assets are located in the PRC. The learning services that the company offers include Traditional Learning Services, Non-Academic Tutoring Services, and College Student and Adult Education Services. It derives maximum revenue from Learning Services and also from Educational content & digitalized learning products.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: